Torun Malmlöf

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias
    Torun Malmlöf
    Department of Physiology and Pharmacology, Section of Neuropsychopharmacology, Karolinska Institutet, Stockholm, Sweden
    Exp Neurol 225:408-15. 2010
  2. ncbi Altered behavioural and neurochemical profile of L-DOPA following deuterium substitutions in the molecule
    Torun Malmlöf
    Department of Physiology and Pharmacology, Section of Neuropsychopharmacology, Karolinska Institutet, 171 77 Stockholm, USA
    Exp Neurol 212:538-42. 2008

Detail Information

Publications2

  1. ncbi Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias
    Torun Malmlöf
    Department of Physiology and Pharmacology, Section of Neuropsychopharmacology, Karolinska Institutet, Stockholm, Sweden
    Exp Neurol 225:408-15. 2010
    ..D3-L-DOPA may thus represent a novel strategy to reduce the total dose requirement and yet achieve an effective control of parkinsonian symptoms...
  2. ncbi Altered behavioural and neurochemical profile of L-DOPA following deuterium substitutions in the molecule
    Torun Malmlöf
    Department of Physiology and Pharmacology, Section of Neuropsychopharmacology, Karolinska Institutet, 171 77 Stockholm, USA
    Exp Neurol 212:538-42. 2008
    ....